Overview
This course originally streamed LIVE on May 14, 2025. it is now avaiable on-demand 24/7 with CME and MOC credit until May 14, 2026.
Objectives
- Describe the healthcare costs, patient-related outcome costs and risks associated with penicillin allergy labeling
- Discuss the importance of clinical history taking in risk stratification and subsequent decision making regarding penicillin allergy de-labeling
- Identify situations where direct oral challenge to penicillin is warranted and in contrast when skin testing is recommended in the evaluation of the patient with penicillin allergy
Credit & Accreditation Statements
 |
|
Accreditation Statement: The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement: The Northwestern University Feinberg School of Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
American Board of Pediatrics
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
AMERICAN BOARD OF SURGERY ACCREDITED CME AND SELF-ASSESSMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery's Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to the ACCME for the purpose of granting ABS credits
ABS CME credits will be submitted to the boards within 3 months of the conclusion of the activity.
|
Disclosures
Lurie Children's CME Leadership & Staff:
Ravi Jhaveri, MD, Course Director; Alyssa Higgins Joyce, MD, MPH, CME Planning Committee; Claudia Cooper,CME Manager
FSM's CME Leadership & Staff:
Clara J. Schroedl, CME Medical Director; Sheryl Corey, CME Manager; Senior Program Coordinator, Allison McCollum; Administrative Assistant, Rhea Alexis Banks have nothing to disclose.
Speakers / Course Directors:
Ravi Jhaveri, MD, course director discloses that he contributes to the editorial services for Elsevier; is involved in the clinical trial planning for Seqirus; receives a consulting fee from Hologic and participates in contracted research for Saol Therapeutics.
Alanna Higgins Joyce, MD,MPH, course directorr has nothing to disclose
Nashmia Qamar, DO, MSCI speaker has nothing to disclose
